Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
03/2010
03/25/2010WO2010031828A1 Tyrosine kinase receptor tyro3 as a therapeutic target in the treatment of cancer
03/25/2010WO2009149288A3 Extracts of cranberry and methods of using thereof
03/25/2010WO2009127974A3 Pharmaceutical formulation for treating cardiovascular disease
03/25/2010US20100076188 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome
03/25/2010US20100076038 Therapeutic agent for urinary excretion disorder
03/25/2010US20100075986 Oxophenyl-Cyclohexyl-Propanolamine Derivatives, Production And Use Thereof In Therapeutics
03/25/2010US20100074954 Adsorbent for oral administration
03/25/2010US20100074939 Harmine compounds for promoting bone growth
03/25/2010CA2736438A1 Tyrosine kinase receptor tyro3 as a therapeutic target in the treatment of cancer
03/24/2010EP2166010A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
03/24/2010EP2166008A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
03/24/2010EP2165710A1 Tyrosine kinase receptor Tyro3 as a therapeutic target in the treatment of a bladder tumor
03/24/2010EP2164330A1 Serca2 therapeutic compositions and methods of use
03/24/2010EP1389110B1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/24/2010CN101679324A 吗啉衍生物 Morpholine derivatives
03/24/2010CN101679273A 1-substituted tetrahydroisoquinoline compound
03/24/2010CN101679251A (Aza)indole derivative and use thereof for medical purposes
03/24/2010CN101679246A Novel pyrrolinone derivative and medicinal composition containing the same
03/24/2010CN101679243A atropisomer of pyrrole derivative
03/24/2010CN101678085A The use of alkaline phosphatase in the treatment of reduced renal function
03/24/2010CN101678071A Prophylactic agent for renal failure
03/24/2010CN101678062A Drugs for treating and preventing benign prostatic hyperplasia, prostatitis, impotency, infertility and prostate cancer and a method for the use thereof
03/24/2010CN101678050A Human umbilical tissue-derived cell compositions for the treatment of incontinence
03/24/2010CN101677975A n1,n4-bis(buta-1,3-dienyl)butane-1,4-diamine pharmaceutical compositions and methods thereof
03/24/2010CN101676297A Preparation method of sea cucumber active polypeptide under ultrasonic extraction
03/24/2010CN101676266A Deuterium-substituted omega-diphenylurea and its derivatives, as well as pharmaceutical composition containing the same
03/24/2010CN101675962A traditional Chinese medicine composition for treating prostatitis
03/24/2010CN101675957A Preparation method of antiphlogistic by using Chinese herbal medicaments as raw materials
03/24/2010CN101675956A Antiphlogistic prepared from Chinese herbal medicaments as raw materials
03/24/2010CN101675950A A traditional Chinese medicine preparation for treating diabetic nephropathy, and preparation method and application thereof
03/24/2010CN101675938A Preparation method and use of a novel peptide type immunizing agent whole-egg protein peptide
03/24/2010CN101675927A therapeutic molecules and methods-1
03/24/2010CN100594925C Medicament for treating chronic kidney disease proteinuria and preparation thereof
03/24/2010CN100594922C Use of nicandra physaloides in preparation of drug for the treatment of chronic prostatitis and prostatic hyperplasia
03/24/2010CN100594920C Kidney-replenishing sperm-supplementing granule
03/23/2010US7683164 Nucleic acid derivatives
03/23/2010US7683094 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder
03/23/2010US7683078 Neuronal disorders, autoimmune diseases, cancer, cardiovascular diseases; such as 4-Chloro-N-{5-[1-(4-trifluoromethyl-benzyl)-piperidin-3-ylsulfamoyl]-25 thiophen-2-ylmethyl)-benzamide
03/23/2010US7683074 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents
03/23/2010US7683061 rheumatoid arthritis, systemic lupus erythematosus (SLE), idiopathic (immune) thrombocytopenia (ITP), glomerulonephritis and vasculitis; reduced drug toxicity
03/23/2010US7682623 Pharmaceutical composition for topical application
03/23/2010CA2352436C Polymorphs of telmisartan, processes for preparing them and their use in the preparation of a pharmaceutical composition
03/23/2010CA2311755C Therapeutic formulation for administering tolterodine with controlled release
03/18/2010WO2009140137A9 Naphthylmethylimidizoles for the treatment of stress urinary incontinence
03/18/2010US20100069500 Amide dendrimer compositions
03/18/2010US20100069379 Bicyclic androgen and progesterone receptor modulator compounds and methods
03/18/2010US20100068273 Pharmaceutical formulation, its use, and method for its manufacture
03/18/2010US20100068177 Methods of organ regeneration
03/18/2010US20100068167 Low Salt Forms of Polyallylamine
03/17/2010EP2163546A1 Quinazoline derivatives
03/17/2010EP2163254A1 Use of HGF for the manufacture of a medicament for treating fibrotic disorders
03/17/2010EP1513814B1 Novel piperidine compound
03/17/2010EP1303536B1 Novel fibroblast growth factor (fgf23) and methods for use
03/17/2010CN101675059A Macrocyclic compound
03/17/2010CN101671389A Erythrocyte generating characteristic-free erythropoietin with nervous protecting function and application thereof
03/17/2010CN101671380A 5-alpha reductase inhibitor-smartweed diffractive ring lignan glucoside B and preparation method thereof
03/17/2010CN101671379A 5-alpha reductase inhibitor-smartweed diffractive ring lignan glucoside A and preparation method thereof
03/17/2010CN101671260A Method for preparing O-desmethyl-venlafaxine
03/17/2010CN101670097A Application of cartilage oligomeric matrix protein in preparing medicine for treating vascular-calcification
03/17/2010CN101670077A Attenuated compatibility formula of minor Chinese thorowax root decoction
03/17/2010CN101670076A Traditional Chinese medicine composition for treating disease of chronic nephritis and preparation method thereof
03/17/2010CN101670055A Traditional Chinese medicine composition for treating disease of pyelonephritis and preparation method
03/17/2010CN101670054A Chinese medicinal material with multiple efficacies
03/17/2010CN101670049A Traditional Chinese medicine for treating kidney stone and preparation method thereof
03/17/2010CN101670007A Drug for preventing and treating kidney diseases and preparation method thereof
03/17/2010CN101669989A Combination containing clerodendranthus spicatus water extract
03/17/2010CN101669988A Extraction process of clerodendranthus spicatus
03/17/2010CN101669912A Slow-release composition containing tamsulosin and preparation thereof
03/17/2010CN101669900A Polymeric delivery formulations of leuprolide with improved efficacy
03/16/2010US7678930 Process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid
03/16/2010US7678834 Substituted 4-aminocyclohexanol compounds
03/16/2010US7678812 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
03/16/2010US7678810 activin receptor-like kinase 5 (ALK5) (which is a TGF- beta type I receptor) inhibitor ; glomerulonephritis, diabetic nephropathy, hepatic fibrosis, liver cirrhosis, pulmonary fibrosis, or alopeciarosis; hair growth stimulant
03/16/2010US7678777 increase a person immunity by oral administering a mixture including a dextran, promoting the cell growth and colonizing in the intestine of a subject without supplying L. casei subsp. casei at all times
03/16/2010US7678775 ILK inhibitors for the treatment of renal disease
03/16/2010CA2510519C Condensed furan compounds
03/16/2010CA2437718C Carboline derivatives
03/16/2010CA2390590C Adenosine receptor antagonists and methods of making and using the same
03/16/2010CA2386980C Benzodiazepine derivatives for use in acute or chronic neurological disorders
03/16/2010CA2372575C Bradykinin receptor antagonists
03/16/2010CA2200054C Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
03/11/2010WO2010027090A1 Therapeutic agent for uremia
03/11/2010WO2010027005A1 Substituted amine derivative and medicinal composition comprising same as the active ingredient
03/11/2010WO2010027002A1 Ring-fused morpholine derivative having pi3k-inhibiting activity
03/11/2010WO2010026993A1 Method for improving absorbability of preparation, and preparation having improved absorbability
03/11/2010WO2010026094A1 Detection and use of low molecular-weight modulators of the cold-menthol receptor trpm8
03/11/2010WO2009153500A3 Plant-based compositions and uses
03/11/2010WO2009109654A3 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxcr1 and p40
03/11/2010WO2009088860A3 A method of preventing contrast-induced nephropathy
03/11/2010WO2009071947A3 Potassium ion channel modulators and uses thereof
03/11/2010US20100063095 Hemiasterlin derivatives and uses thereof in the treatment of cancer
03/11/2010US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators
03/11/2010US20100062024 Biologically Active Hemagglutinin From Type A Clostridium Botulinum and Methods of Use
03/11/2010US20100061985 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
03/11/2010DE102008051572A1 Herstellung von Phosphatbindern und auf diese Weise hergestellte Phosphatbinder Preparation of phosphate binders and phosphate binders thus prepared
03/11/2010CA2734682A1 Detection and use of low molecular-weight modulators of the cold-menthol receptor trpm8
03/10/2010EP2161329A1 Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
03/10/2010EP2161282A1 Peptide analogues of PACAP
03/10/2010EP2161032A2 Methods of healing wounds by administering human IL-18
03/10/2010EP1660104B1 Pharmaceutical formulation comprising lanthanum compounds
1 ... 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 ... 562